Astellas US promotes Jeffrey Bloss to SVP of medical affairs for the Americas

The US subsidiary of Japanese drug major Astellas Pharma (TYO: 4503) announced that Jeffrey Bloss has been promoted to the position of senior vice president, medical affairs Americas, Astellas Scientific and Medical Affairs (ASMA), effective April 1. Dr Bloss will serve as a member of the Astellas US management committee.

"Jeff has been a key partner and thought leader to the global medical affairs function since joining Astellas in 2012," said Masao Yoshida, chief executive of Astellas US.

Since coming to Astellas in October of 2012, Dr Bloss has been responsible for leading the America's regional medical affairs function, including medical information and publications, therapeutic area medical directors, medical scientific liaisons, health economy and clinical outcomes research, independent medical education and medical affairs operations. Dr Bloss has also assumed direct oversight of the medical affairs functions in Canada and Brazil, and he has established strong collaborations with other functions throughout the company to optimize medical/scientific value across the product lifecycle.